🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Nebraska › Omaha

Etid klinik pou Kansè (tout kalite) nan Omaha, NE

18 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • Nebraska Medicine, Omaha
  • Nebraska Medicine - Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Ap rekriteFaz 3
  • University of Nebraska Medical Center, Omaha
  • Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Ap rekriteFaz 2
  • University of Nebraska Medical Center, Omaha
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Ap rekriteFaz 2/3
  • University Of Nebraska Medical Center, Omaha
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Ap rekriteFaz 2
  • University of Nebraska Medical Center, Omaha
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Ap rekriteFaz 1
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07660055

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Children's Hospital and Medical Center of Omaha, Omaha
  • University of Nebraska Medical Center, Omaha
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • ak 8 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Omaha
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2025 · NCT05970497

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Ap rekriteEtid obsèvasyon
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medicine, Omaha
  • Nebraska Medicine - Bellevue, Bellevue · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.